Andrew Levy
8Patents
4h-index
3Co-inventors
50Inventor score
Filing activity: Feb 8, 1994 → Jan 27, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5480975A | Induction of vascular endothelial growth factor (VEGF) by transition metals | Human Necessities | 23 | Expired |
| US6251608A | Method of determining a potential of a hyperglycemic patients of developing vascular complications | Physics | 9 | Expired |
| US6613519B1 | Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease | Physics | 5 | Expired |
| US6599702B1 | Method of evaluating a risk of a subject of developing vascular complications | Physics | 5 | Expired |
| US7608393B2 | Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients | Physics | 1 | Expired |
| US12116611B2 | Method of treating intellectual disability, autism and epilepsy associated with an IQSEC2 mutation and for identifying medicaments for treating the same | Human Necessities | 0 | Active |
| US8901282B2 | Reagents and methods for detecting a polymorphic protein | Physics | 0 | Active |
| US9518993B2 | Reagents and methods for detecting a polymorphic protein | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.